67 related articles for article (PubMed ID: 20498176)
1. On-time vaccine receipt in the first year does not adversely affect neuropsychological outcomes.
Smith MJ; Woods CR
Pediatrics; 2010 Jun; 125(6):1134-41. PubMed ID: 20498176
[TBL] [Abstract][Full Text] [Related]
2. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
Tozzi AE; Bisiacchi P; Tarantino V; De Mei B; D'Elia L; Chiarotti F; Salmaso S
Pediatrics; 2009 Feb; 123(2):475-82. PubMed ID: 19171612
[TBL] [Abstract][Full Text] [Related]
3. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
[TBL] [Abstract][Full Text] [Related]
4. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of influenza immunization for inner-city children aged 6 to 23 months.
Zimmerman RK; Hoberman A; Nowalk MP; Lin CJ; Greenberg DP; Weinberg ST; Bemm CW; Block B
Am J Prev Med; 2004 Dec; 27(5):397-403. PubMed ID: 15556740
[TBL] [Abstract][Full Text] [Related]
6. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
7. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
[TBL] [Abstract][Full Text] [Related]
8. Number of antigens in early childhood vaccines and neuropsychological outcomes at age 7-10 years.
Iqbal S; Barile JP; Thompson WW; DeStefano F
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1263-70. PubMed ID: 23847024
[TBL] [Abstract][Full Text] [Related]
9. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
[TBL] [Abstract][Full Text] [Related]
10. Survival of previously measles-vaccinated and measles-unvaccinated children in an emergency situation: an unplanned study.
Aaby P; Garly ML; Balé C; Martins C; Jensen H; Lisse I; Whittle H
Pediatr Infect Dis J; 2003 Sep; 22(9):798-805. PubMed ID: 14506371
[TBL] [Abstract][Full Text] [Related]
11. [Vaccinations in early infancy -- results of an epidemiological cross-sectional study in Hamburg].
Fell G; David C; Reintjes R
Gesundheitswesen; 2005 Jan; 67(1):27-32. PubMed ID: 15672303
[TBL] [Abstract][Full Text] [Related]
12. Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study.
Jackson LA; Neuzil KM; Baggs J; Davis RL; Black S; Yamasaki KM; Belongia E; Zangwill KM; Mullooly J; Nordin J; Marcy SM; DeStefano F
Pediatrics; 2006 Nov; 118(5):2032-7. PubMed ID: 17079576
[TBL] [Abstract][Full Text] [Related]
13. Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
American Academy of Pediatrics Committee on Infectious Diseases
Pediatrics; 2008 Apr; 121(4):e1016-31. PubMed ID: 18381500
[TBL] [Abstract][Full Text] [Related]
14. Assessment of nine candidate DTP-vaccines with reduced amount of antigen and/or without adjuvant as a fourth (booster-) dose in the second year of life.
Knuf M; Habermehl P; Faber J; Bock HL; Sänger R; Bogaerts H; Clemens R; Schuind A; du Prel JB; Schmitt HJ
Vaccine; 2006 Jul; 24(27-28):5627-36. PubMed ID: 16740348
[TBL] [Abstract][Full Text] [Related]
15. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
[TBL] [Abstract][Full Text] [Related]
16. Association between health care providers' influence on parents who have concerns about vaccine safety and vaccination coverage.
Smith PJ; Kennedy AM; Wooten K; Gust DA; Pickering LK
Pediatrics; 2006 Nov; 118(5):e1287-92. PubMed ID: 17079529
[TBL] [Abstract][Full Text] [Related]
17. Sex differential effects of routine immunizations and childhood survival in rural Malawi.
Aaby P; Vessari H; Nielsen J; Maleta K; Benn CS; Jensen H; Ashorn P
Pediatr Infect Dis J; 2006 Aug; 25(8):721-7. PubMed ID: 16874172
[TBL] [Abstract][Full Text] [Related]
18. Combination vaccine use and vaccination quality in a managed care population.
Happe LE; Lunacsek OE; Marshall GS; Lewis T; Spencer S
Am J Manag Care; 2007 Sep; 13(9):506-12. PubMed ID: 17803364
[TBL] [Abstract][Full Text] [Related]
19. Parental vaccine safety concerns: results from the National Immunization Survey, 2001-2002.
Allred NJ; Shaw KM; Santibanez TA; Rickert DL; Santoli JM
Am J Prev Med; 2005 Feb; 28(2):221-4. PubMed ID: 15710279
[TBL] [Abstract][Full Text] [Related]
20. Perinatal hepatitis B transmission and vaccination timing in a managed care cohort: assessment of the temporary delay in newborn hepatitis B vaccination due to thimerosal content.
Chang S; Begier EM; Schech SD; Venus P; Shatin D; Braun MM; Ball R
Pediatr Infect Dis J; 2007 Apr; 26(4):329-33. PubMed ID: 17414397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
